3D biomaterial used as 'sponge' for stem cell therapy to reverse arthritis

3D biomaterial used as ‘sponge’ for stem cell therapy to reverse arthritis A 3D biomaterial scaffold design to slowly release stem cells ensures that implanted stem cells stick around to…

Cyrogel sponge slowly releases stem cells to reverse arthritis in mice

Cyrogel sponge slowly releases stem cells to reverse arthritis in mice With no real forms of treatment other than pain-relieving medications or a full joint replacement, osteoarthritis remains a difficult…

A Short Delay Is Still Bad News for AbbVie

A Short Delay Is Still Bad News for AbbVie Rinvoq’s FDA approval decision could be a sign the drug class is under investigation. Read More…

Some People’s Bodies Aren’t Set Up for Vaccines

Some People’s Bodies Aren’t Set Up for Vaccines Many immunocompromised people can’t count on what the rest of us can—that the COVID-19 vaccines will protect them from the coronavirus. Read…

India's desperate Covid-19 patients turn to black market for drugs

India’s desperate Covid-19 patients turn to black market for drugs Amid a punishing third wave, people across India are finding drugs, oxygen and beds in short supply. Read More…

Treatment Triggers Teeth to Thrive

Treatment Triggers Teeth to Thrive We humans like to think we’re pretty advanced, but we can’t regrow missing teeth in adulthood like sharks, alligators, and crocodiles. Once those pearly whites…

Novartis agrees to make ingredients Roche's Actemra for COVID-19 patients – Reuters

Novartis agrees to make ingredients Roche’s Actemra for COVID-19 patients – Reuters Swiss drugmaker Novartis has signed a deal to make ingredients for Roche’s Actemra treatment that is being repurposed…

Prince Harry has been seen back in the UK ahead of Prince Philip's funeral – Yahoo Canada Shine On

Prince Harry has been seen back in the UK ahead of Prince Philip’s funeral – Yahoo Canada Shine On Prince Harry has been seen back in the UK ahead of…

Cipla doubles remdesivir production to meet 'unprecedented' demand – Reuters

Cipla doubles remdesivir production to meet ‘unprecedented’ demand – Reuters India’s Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet “unprecedented demand” as the country battles a…

Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant – Reuters

Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant – Reuters The following is a roundup of some of the latest scientific studies on the novel coronavirus…